Sign Up to like & get
recommendations!
0
Published in 2025 at "JCI Insight"
DOI: 10.1172/jci.insight.181496
Abstract: BACKGROUND HIV-1–specific broadly neutralizing monoclonal antibodies (bNAbs) have emerged as promising interventions with the potential to effectively treat and prevent HIV-1 infections. We conducted a phase I clinical trial evaluating the potent CD4-binding site–specific (CD4bs-specific)…
read more here.
Keywords:
vrc01ls vrc07;
hiv;
trial;
broadly neutralizing ... See more keywords